MedPath

LEADING PHARMA, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

40

FDA:40

Drug Approvals

OFLOXACIN

Approval Date
Mar 22, 2024
FDA

NYSTATIN

Approval Date
Mar 19, 2024
FDA

KETOROLAC TROMETHAMINE

Approval Date
Feb 16, 2024
FDA

VARENICLINE TARTRATE

Approval Date
Feb 10, 2024
FDA

ETRAVIRINE

Approval Date
Jan 10, 2024
FDA

ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE

Approval Date
Jan 10, 2024
FDA

OSELTAMIVIR PHOSPHATE

Approval Date
Jan 10, 2024
FDA

DICLOFENAC POTASSIUM

Approval Date
Jan 4, 2024
FDA

Lorazepam

Approval Date
Dec 10, 2023
FDA

Allopurinol

Approval Date
Oct 6, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.